Table 1
VL Endpoint (copies/mL) | EFV/FTC/TDF | SBR | Difference EFV/FTC/TDF – SBR (95% CI) |
|---|---|---|---|
<200 by TLOVR | 89% | 88% | 1.1% (-6.7%, 8.8%) |
<50 by TLOVR | 87% | 85% | 2.6% (-5.9%, 11.1%) |
<50 by PVR | 95% | 86% | 8.9% (-7.7%, 25.6%) |
<50 by LOCF | 94% | 97% | -3.3% (-8.3%, 2.7%) |
VL Endpoint (copies/mL) | EFV/FTC/TDF | SBR | Difference EFV/FTC/TDF – SBR (95% CI) |
|---|---|---|---|
<200 by TLOVR | 89% | 88% | 1.1% (-6.7%, 8.8%) |
<50 by TLOVR | 87% | 85% | 2.6% (-5.9%, 11.1%) |
<50 by PVR | 95% | 86% | 8.9% (-7.7%, 25.6%) |
<50 by LOCF | 94% | 97% | -3.3% (-8.3%, 2.7%) |